Evidence map›Paper›PMID 32304824›Full record

ArticleMolecular and cellular probes2020

Development of qPCR platform with probes for quantifying prevalent and biomedically relevant human gut microbial taxa.

Irina Kurina, Anna Popenko, Natalia Klimenko, Stanislav Koshechkin, Liubov Chuprikova, Maxim Filipenko, Alexander Tyakht, Dmitry Alexeev

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular probes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Impact of lactic acid bacteria andVeterinary and animal science · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Analysis of the gut microbiome in dogs and cats.Veterinary clinical pathology · 2022
    Review
  11. A Comprehensive Evaluation ofPathogens (Basel, Switzerland) · 2021
    Article
  12. Article
  13. Article
  14. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Irina KurinaKnomics LLC, Skolkovo Innovation Center, Bolshoy Bulvar str., building 42, premise 1, room 1639, Moscow, 143026, Russia; Atlas Biomed Group, 31 Malaya Nikitskaya str., 121069, Moscow, Russia. Electronic address: kurina@atlas.ru.
Anna PopenkoKnomics LLC, Skolkovo Innovation Center, Bolshoy Bulvar str., building 42, premise 1, room 1639, Moscow, 143026, Russia; Atlas Biomed Group, 31 Malaya Nikitskaya str., 121069, Moscow, Russia.
Natalia KlimenkoKnomics LLC, Skolkovo Innovation Center, Bolshoy Bulvar str., building 42, premise 1, room 1639, Moscow, 143026, Russia; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Gene Biology Russian Academy of Sciences, 34/5 Vavilova str., 119334, Moscow, Russia.
Stanislav KoshechkinKnomics LLC, Skolkovo Innovation Center, Bolshoy Bulvar str., building 42, premise 1, room 1639, Moscow, 143026, Russia.
Liubov ChuprikovaKnomics LLC, Skolkovo Innovation Center, Bolshoy Bulvar str., building 42, premise 1, room 1639, Moscow, 143026, Russia.
Maxim FilipenkoInstitute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 8 Lavrentiev ave., Novosibirsk, 630090, Russia.
Alexander TyakhtKnomics LLC, Skolkovo Innovation Center, Bolshoy Bulvar str., building 42, premise 1, room 1639, Moscow, 143026, Russia; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Gene Biology Russian Academy of Sciences, 34/5 Vavilova str., 119334, Moscow, Russia. Electronic address: a.tyakht@gmail.com.
Dmitry AlexeevKnomics LLC, Skolkovo Innovation Center, Bolshoy Bulvar str., building 42, premise 1, room 1639, Moscow, 143026, Russia; Atlas Biomed Group, 31 Malaya Nikitskaya str., 121069, Moscow, Russia.
Skolkovo Foundation · RUInstitute of Chemical Biology and Fundamental Medicine · RUInstitute of Gene Biology · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nowadays the advent of innovative high-throughput sequencing allows obtaining high-quality microbiome profiling. However, PCR-based tests are still considered the "golden standard" for many clinical applications. Here, we designed a qPCR-based platform with fluorescent-labeled oligonucleotide probes for assessing human gut microbiome composition. The system allows conducting qualitative and semiquantitative analysis for 12 prokaryotic taxa that are prevalent in the human gut and associated with diseases, diet, age and other factors. The platform was validated by comparing microbiome profile data obtained with two different methods - the platform and high-throughput 16S rRNA sequencing - across 42 stool samples. The test can form the basis for precise and cost-efficient microbiome assay for large-scale surveys including clinical trials with interventions related to diet and disease risks.

Indexed as

PhylogenyDNA PrimersDNA ProbesFecesGastrointestinal MicrobiomeHigh-Throughput Nucleotide SequencingPolymerase Chain ReactionRNA, Ribosomal, 16SDNA PrimersDNA ProbesRNA, Ribosomal, 16SDietGut microbiomeMicrobial biomarkersNutrition assessment techniqueQuantitative real-time PCRRespondersTaxonomic profiling

Identifiers

PMID32304824
PMCPMC7158812
OpenAlexW3016671995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.